EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro

Miyako Shimasaki, Shusuke Ueda iD, Masaru Sakurai, Norio Kawahara, Yoshimichi Ueda, Toru Ichiseki

Biomolecules · 2024

DOI: 10.3390/biom14121636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Miyako Shimasaki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology 2, Kanazawa Medical University, Daigaku 1-1, Uchinada-machi, Kahoku-gun 920-0293, Japan. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Celecoxib, Chondrocytes, Anti-Inflammatory Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and oxidative stress are crucial for osteoarthritis (OA) pathogenesis. Despite the potential of pharmacological pretreatment of chondrocytes in preventing OA, its efficacy in preventing the progression of cartilage damage and promoting its recovery has not been examined. In this study, an H2O2-induced human OA-like chondrocyte cell model was created using H1467 primary human chondrocytes to evaluate the efficacy of interleukin (IL)-6 and cyclooxygenase (COX)-2 inhibitors (tocilizumab and celecoxib, respectively) in the prevention and treatment of cartilage damage. H2O2 significantly elevated the IL-6, COX-2, and matrix metalloproteinase (MMP)-13 levels. Although monotherapy decreased the levels, nuclear shrinkage and altered cell morphology, similar to those in the H2O2 group, were observed. The expression of these factors was significantly lower in the combination therapy group, and the cell morphology was maintained. Moreover, the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway was activated, and levels of the antioxidant protein heme oxygenase-1 (HO-1) were increased, especially in the combination group, indicating an anti-inflammatory effect. The treatment groups, particularly the combination group, demonstrated increased cell viability. Overall, the drug combination exhibited superior efficacy in preventing the progression of cartilage damage and promoted its recovery compared with the monotherapy. Given that the drugs herein are already in clinical use, they are suitable candidates for OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2CelecoxibChondrocytesAnti-Inflammatory AgentsOsteoarthritisAntibodies, Monoclonal, HumanizedSignal TransductionHumansHeme Oxygenase-1Interleukin-6Hydrogen PeroxideMatrix Metalloproteinase 13Cartilage, ArticularCyclooxygenase 2Oxidative StressCell Line

Stichwörter der Autor:innen

Nrf2antioxidantcartilage damagecelecoxibchondrocytesheme oxygenase-1oxidative stresstocilizumab

Substanzen

NF-E2-Related Factor 2CelecoxibNFE2L2 protein, humanAnti-Inflammatory AgentstocilizumabAntibodies, Monoclonal, HumanizedHMOX1 protein, humanHeme Oxygenase-1Interleukin-6Hydrogen Peroxide

Autor:innen und Institutionen

  • Department of Pathology 2, Kanazawa Medical University, Daigaku 1-1, Uchinada-machi, Kahoku-gun 920-0293, Japan.
  • Department of Orthopaedic Surgery, Kanazawa Medical University, Daigaku 1-1, Uchinada-machi, Kahoku-gun 920-0293, Japan.
  • Social and Environmental Medicine, Kanazawa Medical University, Daigaku 1-1, Uchinada-machi, Kahoku-gun 920-0293, Japan.
  • Department of Pathology, Keiju Medical Center, 94, Tomioka-machi, Nanao 926-0816, Japan.
  • Division of Translational Research, Department of Life Science, Medical Research Institute, Kanazawa Medical University, Daigaku 1-1, Uchinada-machi, Kahoku-gun 920-0293, Japan.

ORCID-Profile: Shusuke Ueda

Zitieren

APA

Shimasaki, M., Ueda, S., Sakurai, M., Kawahara, N., Ueda, Y., & Ichiseki, T. (2024). Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro. Biomolecules. https://doi.org/10.3390/biom14121636

Vancouver

Shimasaki M, Ueda S, Sakurai M, Kawahara N, Ueda Y, Ichiseki T. Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro. Biomolecules. 2024. doi:10.3390/biom14121636

BibTeX
@article{Shimasaki2024,
  author = {Shimasaki, Miyako and Ueda, Shusuke and Sakurai, Masaru and Kawahara, Norio and Ueda, Yoshimichi and Ichiseki, Toru},
  title = {Celecoxib Combined with Tocilizumab Has Anti-Inflammatory Effects and Promotes the Recovery of Damaged Cartilage via the Nrf2/HO-1 Pathway In Vitro},
  journal = {Biomolecules},
  year = {2024},
  doi = {10.3390/biom14121636}
}
Kostenlos starten →